ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders

British Medical Journal

Volumn 325, Issue 7373, 2002, Pages 1161-1163

  Lip, Gregory Y H ^a   Kamath, Sridhar ^a   Hart, Robert G ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; WARFARIN;

ADULT; AGE; AGED; AGING; ALGORITHM; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INDUCED DISEASE; EMBOLISM; FEMALE; GENDER; HUMAN; HYPERTENSION; INCIDENCE; MALE; OBESITY; ONSET AGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SHORT SURVEY; SMOKING; STROKE; SUSTAINED RELEASE PREPARATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0037121312     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.325.7373.1161     Document Type: Short Survey

References (0)